CURE’s gastric cancer page is a go-to resource for oncology news and updates in the world of gastric cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in gastric cancer.

Latest News

Imfinzi plus chemo cut progression or death risk in early gastric cancer: © stock.adobe.com.
FDA Grants Priority Review to Imfinzi for Early Gastric Cancers

July 29th 2025

Imfinzi plus chemo cut progression or death risk in early gastric cancer; the FDA's decision is expected late 2025 following breakthrough designation.

Photo of a person with an illustrated gastrointestinal tract in front of them
Zanzalintinib Combo Improves Survival in Metastatic Colorectal Cancer

June 25th 2025

Image of stomach.
Imfinzi Combo Boosts Survival in Resectable Gastric and GEJ Cancer

June 2nd 2025

Second-line Enhertu improved key survival end points versus Cyramza plus paclitaxel for HER2+ gastric cancer or gastroesophageal junction adenocarcinoma: © stock.adobe.com.
Enhertu Improves Survival End Points Vs Cyramza/Paclitaxel in HER2+ GC/GEJ

May 31st 2025

Clinical trials text.
Clinical Trials Enhance Care for Advanced Gastrointestinal Cancers

April 21st 2025

Video Interviews
Podcasts
Image of CURE's Cancer Horizons podcast logo: a white microphone with yellow noise lines. Highlights from the 2024 ASCO gastrointestinal and genitourinary cancer conferences.
Dr. Dusty Deming in the lab.   Photo courtesy of UW Health
Last week, the FDA provided updates on two cancer therapies. In this episode, we discuss those decisions and more.
cancer horizons logo
William S. Laird standing in front of a car |  Photo credit: Bernd Gustavsson
Teri Greige with medals

More News